Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
July 25, 2024
From CNBC.com News
From CNBC.com News
CNBC Daily Open: Rising geopolitical risk
July 18, 2024
From CNBC.com News
CNBC Daily Open: Rising geopolitical risk
July 17, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 03, 2024
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
July 02, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
From CNBC.com News
Jim Cramer's top picks for pet-centric stocks
June 25, 2024
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
June 25, 2024
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
June 24, 2024
From CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
June 21, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.